MedTrace Logo

Safety and Clinical Performance of the Yukon Choice PC, Yukon Chrome PC & Yukon Choice Flex Stents in Routine Practice

NCT05703646 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2023-11-27

No results posted yet for this study

Summary

The goal of this observational study is to collect safety and performance information in the setting of a large-scale clinical registry.

Patients meeting the selection criteria will be included, in chronological order of their implantation. This registry does not require any additional procedures, follow-up interventions, or ionizing radiation for patients.

The inclusion period is planned to last 2 years, starting in Q1 2023. The study will be complete when data on all patient's follow-up for one year have been collected.

Conditions

  • Ischemic Heart Disease

Sponsors & Collaborators

  • EVAMED

    collaborator OTHER

  • Translumina GmbH

    lead INDUSTRY

Principal Investigators

  • ROBERT BYRNE, Professor · Cardiovascular Research RCSI University of Medicine and Health Sciences, Dublin, Ireland

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-30
Primary Completion
2026-03-30
Completion
2026-03-30

Countries

  • United Arab Emirates

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05703646 on ClinicalTrials.gov